| MAFG |
MAFG: Transcription factor MafG |
NFE2L2 |
NFE2L2, NRF2: Nuclear factor erythroid 2-related factor 2 |
1.17 |
Evidence |
O
|
| TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
CRKL |
CRKL: Crk-like protein |
1.17 |
Evidence |
|
| MMP2 |
MMP2, CLG4A: 72 kDa type IV collagenase precursor |
HAPLN1 |
HAPLN1, CRTL1: Hyaluronan and proteoglycan link protein 1 precursor |
1.17 |
Evidence |
|
| GNAT2 |
GNAT2, GNATC: Guanine nucleotide-binding protein G(t), alpha-2 subunit |
HTR2C |
HTR2C, HTR1C: 5-hydroxytryptamine receptor 2C |
1.17 |
Evidence |
|
| NCK2 |
NCK2: Cytoplasmic protein NCK2 |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
1.17 |
Evidence |
|
| FRK |
FRK, PTK5, RAK: Tyrosine-protein kinase FRK |
RIN1 |
RIN1: Ras and Rab interactor 1 |
1.17 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
VDP |
DKFZp451D234: Putative uncharacterized protein DKFZp451D234 |
1.167 |
Evidence |
|
| HNRPH3 |
HNRPH3: Heterogeneous nuclear ribonucleoprotein H3 |
TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
1.167 |
Evidence |
|
| RAC1 |
IPI00219675 |
CCNB1 |
Cyclin B1 |
1.167 |
Evidence |
|
| STAT3 |
|
EP300 |
IPI00478752 |
1.167 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
MKNK1 |
MKNK1, MNK1: MAP kinase-interacting serine/threonine-protein kinase 1 |
1.167 |
Evidence |
|
| APC |
IPI00215877 |
PSEN1 |
PSEN1, AD3, PS1, PSNL1: Presenilin-1 |
1.167 |
Evidence |
|
| PLK1 |
PLK1, PLK: Serine/threonine-protein kinase PLK1 |
CKAP1 |
TBCB, CG22, CKAP1: Tubulin folding cofactor B |
1.167 |
Evidence |
|
| DGKD |
DGKD, KIAA0145: Diacylglycerol kinase delta |
FZR1 |
IPI00099464 |
1.167 |
Evidence |
|
| AKAP8 |
AKAP8, AKAP95: A-kinase anchor protein 8 |
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
1.167 |
Evidence |
|
| PTPN2 |
PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 |
CDC25A |
CDC25A: M-phase inducer phosphatase 1 |
1.167 |
Evidence |
|
| ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
SMU1 |
SMU1: Smu-1 suppressor of mec-8 and unc-52 protein homolog |
1.167 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
RNF20 |
|
1.167 |
Evidence |
|
| STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
KCNAB2 |
KCNAB2, KCNA2B, KCNK2: Voltage-gated potassium channel subunit beta-2 |
1.167 |
Evidence |
|
| CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
DBNL |
IPI00396437 |
1.167 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
1.167 |
Evidence |
|
| EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
BCR |
IPI00655824 |
1.167 |
Evidence |
|
| GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
RANBP9 |
RANBP9, RANBPM: Ran-binding protein 9 |
1.167 |
Evidence |
|
| GGA3 |
GGA3, KIAA0154: ADP-ribosylation factor-binding protein GGA3 |
GIT1 |
GIT1: ARF GTPase-activating protein GIT1 |
1.167 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
HNRPD |
HNRPD, AUF1: Heterogeneous nuclear ribonucleoprotein D0 |
1.167 |
Evidence |
|
-